Zevra Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Zevra Therapeutics, Inc. (ZVRA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $247.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $247.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $208.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $248.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $291.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $247.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $208.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $248.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $291.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $338.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $405.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $152.00K 10-K · filed 2025-03-12 |
| 2024-09-30 | $172.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $188.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $223.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $64.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $82.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $99.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $121.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $147.00K 10-K · filed 2023-03-07 |
| 2022-09-30 | $172.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $199.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $222.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $251.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $282.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $315.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $349.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $385.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $422.00K 10-Q · filed 2020-10-30 |
| 2020-06-30 | $461.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $539.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $583.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $628.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $675.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |